By Dr Swagat Dash Theranostics is an advanced approach to cancer diagnosis and treatment that combines therapeutics and ...

To our knowledge, this study is the largest to date on the direct determination of BV from PV and RCV in children and adolescents at various pubertal stages. Our pilot study in 31 patients aged 2 ...

The drug candidate is a bombesin analogue radioconjugated radiolabelled with 177Lu. It is based on molecular nuclear therapy that combines two approaches such as tumor targeting and radiation therapy.

The discovery of autoantibodies directed against muscle-specific kinase (MuSK) in “seronegative” myasthenia gravis (MG) patients marked a milestone in MG research. In healthy muscle, MuSK regulates a ...

Satoreotide is being developed as a ‘theranostic pair’ for the combined diagnosis and targeted radionuclide treatment of these tumours. Ariceum is also developing a radiolabelled PARP-inhibitor ...

However, although PET has greater resolution than fMRI, it is limited by cost and availability. PET studies, using tracers sensitive to blood flow and metabolism (eg, radiolabelled water and ...